羚锐制药：公司高管拟减持不超过20万股公司股份

Core Viewpoint - The announcement from Lingrui Pharmaceutical indicates that the company's Vice President Chen Yan plans to reduce his shareholding due to personal financial needs, which may impact investor sentiment and stock performance [1] Summary by Relevant Sections Shareholding Reduction Plan - Chen Yan intends to reduce his holdings by up to 200,000 shares, which represents no more than 0.0353% of the company's total share capital and up to 25% of his total shareholding [1] - The reduction will occur within three months after a 15 trading day period following the announcement, excluding the window period [1] Current Shareholding Status - As of the announcement date, Chen Yan holds 965,000 shares, accounting for 0.17% of the company's total share capital [1]